Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
VKTX
Stock Latest News
The Fly
Viking Therapeutics’ VK2735 demonstrates wieght loss in Phase 2 trial
12d ago
VKTX
Premium
The Fly
Viking Therapeutics call volume above normal and directionally bullish
20d ago
VKTX
Premium
Ratings
Nash Maintains Buy on Viking Therapeutics, Keeps $107 Price Target Unchanged Amid Strong Cash Runway and Expanded VK2735 Study
20d ago
VKTX
Premium
The Fly
Viking Therapeutics price target lowered to $100 from $105 at Cantor Fitzgerald
24d ago
VKTX
Premium
The Fly
Viking Therapeutics price target lowered to $95 from $99 at Morgan Stanley
24d ago
VKTX
Premium
Ratings
Viking Therapeutics Maintained at Buy as VK2735 Advances Through Phase 3, Price Target Reaffirmed at $102
24d ago
VKTX
Premium
The Fly
Viking Therapeutics reports Q1 EPS ($1.37), consensus (91c)
25d ago
VKTX
Premium
The Fly
Viking Therapeutics options imply 7.0% move in share price post-earnings
25d ago
VKTX
Premium
Pre-Earnings
VKTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
28d ago
VKTX
Premium
The Fly
Viking Therapeutics call volume above normal and directionally bullish
2M ago
VKTX
Premium
Market News
3 Best Stocks Under $50 to Buy in April 2026, According to Analysts
2M ago
FIGR
ONON
Premium
Ratings
Viking Therapeutics: Accelerated VK2735 Obesity Program and Single‑Molecule Strategy Support Buy Rating and Favorable Risk‑Reward
2M ago
VKTX
Premium
Ratings
Strong Enrollment and Phase 3 Momentum Underpin Buy Rating on Viking Therapeutics’ Obesity Program
2M ago
VKTX
Premium
The Fly
Viking Therapeutics completes enrollment in Phase 3 VANQUISH-2 trial of VK2735
2M ago
VKTX
Premium
Weekend Updates
T-Mobile, AppLovin, ConocoPhillips, Viking, Western Digital Insider Shake-Up
2M ago
APP
COP
Premium
The Fly
Viking Therapeutics management to meet with Truist
3M ago
VKTX
Premium
Ratings
Maintained Buy Rating on Viking Therapeutics Reflects Confidence in Pipeline Strength and Favorable Risk‑Reward Profile
3M ago
VKTX
Premium
The Fly
Viking Therapeutics rises 10.7%
3M ago
VKTX
Premium
The Fly
Unusually active option classes on open February 23rd
3M ago
FRO
SLS
Premium
Weekend Updates
Viking Therapeutics Surges as Obesity Drug Hopes Rise
3M ago
VKTX
Premium
Market News
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
3M ago
BIB
CRBU
Premium
Company Announcements
Viking Therapeutics Bets Big on Obesity Breakthroughs
3M ago
VKTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
